Abstract

Summary

Excessive artificial light at night — particularly blue-wavelength light from LEDs and screens — disrupts melatonin rhythms and circadian organization, increasing risks for metabolic, cardiovascular, and psychiatric disorders. Lighting systems that minimize blue light during evening hours and maximize appropriate daytime light exposure could substantially reduce these health risks.
Abstract

Key Findings

  • Epidemiological studies associate chronodisruption with increased incidence of diabetes, obesity, heart disease, cognitive impairment, premature aging, and certain cancers.
  • Blue light (~480 nm, the primary melanopsin stimulus) induces the strongest melatonin suppression and is most disruptive at night.
  • Proliferation of LEDs and electronic devices is increasing nocturnal blue light exposure in developed populations.
  • Modern indoor environments expose people to significantly lower daytime light intensities than natural conditions, impairing proper circadian entrainment.
  • Lighting systems designed to preserve melatonin rhythm (e.g., reducing blue content at night) are proposed as a practical intervention to mitigate chronodisruption-related health risks.
Categories

Categories

Sleep & Circadian Health: Reviews how light exposure patterns — especially blue light at night — disrupt melatonin rhythms and circadian entrainment, with direct implications for lighting design.
The Science of Light: Discusses melanopsin, ipRGCs, and spectral sensitivity of photoreceptors as the biological basis for understanding how wavelength and timing of light affect the circadian system.
Mood & Mental Wellness: Links chronodisruption to cognitive and affective impairment, obesity, diabetes, and cancer, framing lighting as a public health concern.
Authors

Author(s)

KD Gaitonde
Publication Date

Publication Year

2023
View more publications